Athos Therapeutics develops artificial intelligence-based precision therapeutics for patients with autoimmune diseases and cancer.

Athos Therapeutics Inc

Athos Therapeutics

Developing precision therapeutics for patients with chronic inflammatory diseases incorporating artificial intelligence and machine learning algorithms

Announcing the future of secure, scalable AI Cloud infrastructure: Athos Therapeutics Inc taps Vultr Cloud GPU to power AI drug discovery engine - powered by NVIDIA and running on #Dell #PowerEdge servers: https://dell.to/3KSej6D #TransformHIT Dell Technologies Dell Technologies Partner

Athos has exciting news to share regarding our Artificial Intelligence Development!

Read more below: 

https://lnkd.in/gD3icA3y

Athos Therapeutics participated in the J.P Morgan Conference in Abu Dhabi, organized by the United Al Saqer Group, Blue Horizon Advisors, and the J.P. Morgan Life Sciences Private Capital Team. 

Athos CEO, Dr. DIMITRIOS ILIOPOULOS  participated in an exciting panel discussion related to the emerging biotech hub in Abu Dhabi.

We're #hiring a new Executive Assistant in Torrance, California. Apply today or share this post with your network.

We're #hiring a new Information Technology Engineer in Torrance, California. Apply today or share this post with your network.

We're #hiring a new Director, Preclinical Toxicology & Regulatory Affairs in Los Angeles, California. Apply today or share this post with your network.

COM:ATHOSTX

Athos Therapeutics

locale

market

industry

website

linkedin

founding date

invested in

Metrics